›
^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersTEST:PredicineHEME™
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
PredicineType:
Laboratory Developed Test
Related tests:
PredicineHEME™ is a 106 gene assay that targets known mutations associated with B-cell malignancies including chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and mantle cell lymphoma (MCL).
Cancer:
Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma, Mantle Cell Lymphoma, Small Lymphocytic Lymphoma
Gene:
AKT1 (V-akt murine thymoma viral oncogene homolog 1), ALK (Anaplastic lymphoma kinase), ARID1A (AT-rich interaction domain 1A), ARID1B (AT-Rich Interaction Domain 1B), ASXL1 (ASXL Transcriptional Regulator 1), ATM (ATM serine/threonine kinase)
See More ...
AKT1 (V-akt murine thymoma viral oncogene homolog 1), ALK (Anaplastic lymphoma kinase), ARID1A (AT-rich interaction domain 1A), ARID1B (AT-Rich Interaction Domain 1B), ASXL1 (ASXL Transcriptional Regulator 1), ATM (ATM serine/threonine kinase), BAX (BCL2-associated X protein), BCL2 (B-cell CLL/lymphoma 2), BCL2L1 (BCL2-like 1), BCL6 (B-cell CLL/lymphoma 6), BIRC3 (Baculoviral IAP repeat containing 3), BMI1 (BMI1 proto-oncogene, polycomb ring finger), BRAF (B-raf proto-oncogene), BTK (Bruton Tyrosine Kinase), CARD11 (Caspase Recruitment Domain Family Member 11), CCND1 (Cyclin D1), CCND2 (Cyclin D2), CCND3 (Cyclin D3), PD-L1 (Programmed death ligand 1)
